Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hospice × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 1083 Neoplasms 887 Carcinoma, Non-Small-Cell Lung 731 Prostatic Neoplasms 652 Colorectal Neoplasms 501 Lung Neoplasms 478 Neoplasm Metastasis 367 Multiple Myeloma 352 Leukemia, Myeloid, Acute 336 Ovarian Neoplasms 322 Melanoma 304 Pancreatic Neoplasms 283 Squamous Cell Carcinoma of Head and Neck 253 Recurrence 230 Brain Neoplasms 227 Carcinoma, Hepatocellular 225 Stomach Neoplasms 219 Glioblastoma 200 Endometrial Neoplasms 199 Uterine Cervical Neoplasms 196 Precursor Cell Lymphoblastic Leukemia-Lymphoma 194 Lymphoma 193 Head and Neck Neoplasms 191 Urinary Bladder Neoplasms 190 Triple Negative Breast Neoplasms 186 Carcinoma, Renal Cell 180 Leukemia, Lymphocytic, Chronic, B-Cell 162 Hematologic Neoplasms 161 Lymphoma, Non-Hodgkin 159 Glioma 159

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡